Study of Jitongning Tablet to Treat Spondyloarthritis
Status:
Unknown status
Trial end date:
2021-04-01
Target enrollment:
Participant gender:
Summary
This study is to investigate the efficacy and safety of Jitongning Tablet in improving joint
function and pain symptoms in active axial spondyloarthritis (SpA) patients and to explore
the optimal dosage.